Position in NBP
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$276,658
-$284,307 QoQ
Shares Held
112,463
-20.2% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. NBP ranks #313 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in NBP
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $276,658 | 112,463 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $560,965 | 140,946 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $825,816 | 218,470 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $25,850 | 10,682 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,804 | 10,685 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $9,082 | 10,685 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $13,249 | 10,685 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $26,302 | 15,750 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $157,990 | 84,941 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $275,870 | 145,195 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $318,609 | 241,371 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $880,653 | 294,533 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $1,242,555 | 359,120 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $2,225,766 | 532,480 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $4,564,735 | 1,138,338 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $12,194,903 | 1,079,195 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $11,801,477 | 726,692 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $17,364,596 | 366,419 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $15,263,566 | 210,561 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $11,842,994 | 141,072 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $7,202,738 | 148,602 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $754,730 | 16,007 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,676,289 | 56,906 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||